Sold All: 41 Reduced: 166 Increased: 95 New Position: 52.
The stock increased 0.20% or $0.08 during the last trading session, reaching $41.04. About 289,690 shares traded.
Change of 5.27% for Cyberark Software LTD. - Ordinary Shares (NASDAQ:CYBR)'s shorted shares was noted.
Opaleye Management Inc. holds 0.89% of its portfolio in Chimerix, Inc. for 600,000 shares. Independent Franchise Partners Llp owns 8.22 million shares or 3.55% of their U.S. portfolio. The institutional investors in our database reported: 34.68 million shares, up from 33.85 million shares in 2017Q3. The New York-based Aisling Capital Llc has invested 0.43% in the stock. "Buy" rating has 5, "Sell" are 0, while 4 are "Hold".
Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on April, 25 before the open.
According to Zacks, analysts expect that CyberArk will report full year sales of $69.31 million for the current financial year, with estimates ranging from $314.00 million to $315.97 million. The profit will be $2.49 million for CYBR if $0.07 EPS becomes true. -77.42 % negative EPS growth is what Wall Street's sees after $0.31 reported EPS last quarter. It has a 14.87 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. Therefore 62% are positive. CyberArk has a 52-week low of $39.34 and a 52-week high of $55.63. JMP Securities has "Market Outperform" rating and $53 target. On Friday, February 16 the rating was maintained by Stephens with "Hold". Dougherty & Company initiated the stock with "Buy" rating in Tuesday, July 21 report. On Thursday, November 2 the firm has "Buy" rating by Stifel Nicolaus given. Bank of America upgraded CyberArk from a "neutral" rating to a "buy" rating and lifted their price target for the company from $39.34 to $55.63 in a report on Friday, March 9th. On Thursday, February 15 the company was maintained by Piper Jaffray. Piper Jaffray has "Neutral" rating and $70.0 target. Piper Jaffray upgraded CyberArk Software Ltd. (NASDAQ:CYBR) rating on Tuesday, September 1. Eight equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the stock. The firm earned "Buy" rating on Monday, October 26 by Evercore.
CyberArk Software Ltd. develops, markets, and sells software IT security solutions that protect organizations from cyber attacks in the United States and internationally.The firm is valued at $1.86 billion. Goldman Sachs Group Inc. now owns 40,144 shares of the technology company's stock valued at $1,662,000 after acquiring an additional 2,795 shares during the last quarter. The Company's Privileged Account Security Solution consists of various products, such as Enterprise Password Vault, SSH Key Manager, Privileged Session Manager, Privileged Threat Analytics, Application Identity Manager, Endpoint Privilege Manager and On-Demand Privileges Manager.